"With the Discovery PET/CT family of products, we bring flexibility to the market," said Jim Mitchell, general manager of GE Healthcare's PET business. "We deliver platforms designed to meet the immediate needs of clinicians, while providing researchers with tools to explore the future of molecular imaging."
Pre-clinical Imaging
Ad Statistics
Times Displayed: 125799
Times Visited: 7246 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Opening the door to new diagnostic imaging applications, GE Healthcare's pre-clinical imaging serves the development of new therapeutics and tracers by using newest imaging technologies with animal disease models. The eXplore speCZT, the first full-ring solid-state detector small animal SPECT, focuses on high throughput and rapid dynamic imaging. The system utilizes a cadmium zinc telluride (CZT) detector with high-energy resolution to enable dual or triple radionuclide imaging. Understanding researcher's multi-modality needs, the Triumph pre-clinical system, is an all digital, fully integrated molecular imaging system for biomedical research and pharmaceutical development, designed to accommodate any combination of SPECT, PET, and CT.
Radiopharmacy Systems
Molecular imaging is only possible with the latest in imaging agents and radiopharmaceuticals. GE Healthcare simplifies the complexity of radiopharmacy infrastructure into a single touch-point solution. TRACERcenter-GMP is a combination of equipment, information and services that allow you to establish and operate your research or clinical PET tracer production center with confidence by providing state-of-the-art instrumentation, comprehensive documentation and GMP training and consulting services to provide new centers with support and knowledge for the production of PET tracers.
Innovation Center
GE Healthcare's Innovation Center will feature a look at next-generation molecular imaging concepts, developments and innovations. Attendees will have the opportunity to see how GE is understanding disease, from the beginning.
Radiotracers and Molecular Imaging Agents
GE's advancements in molecular imaging equipment are matched only by our advancements in molecular imaging agents. Featured at SNM 2009 are key products, AdreView™ (Iobenguane I 123) and Myoview™ (99mTc-Tetrofosmin). AdreView, which is approved for use in the U.S. and Europe, is the only FDA-approved I-123 mIBG agent for use in the detection of primary or metastatic pheochromocytoma or neuroblastoma as an adjunct to other diagnostic tests. AdreView is not approved for use in Canada. AdreView is backed by a rigorous prospective clinical trial, and allows use of planar and SPECT imaging.
